Stereotaxis secured official U.S. Food and Drug Administration (FDA) approval for its flagship MAGiC Magnetic Interventional Ablation Catheter. This milestone clearance enables electrophysiologists to utilize the robotically navigated magnetic ablation catheter for treating complex heart rhythm disorders and cardiac arrhythmias, allowing the company to transition toward a high-margin recurring revenue model by pairing its robotic hardware systems with proprietary consumable devices.